Viewing Study NCT05410860

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-03-06 @ 4:05 PM
Study NCT ID: NCT05410860
Status: COMPLETED
Last Update Posted: 2024-12-24
First Post: 2022-06-05
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy and Safety Study of Etripamil Nasal Spray Self-Administration for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia
Sponsor: Corxel Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Tachycardia, Supraventricular View
None Paroxysmal Supraventricular Tachycardia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Etripamil View
None Paroxysmal supraventricular tachycardia View
None Cardiac monitoring View
None Calcium channel blocker View
None Conversion rate View
None Chinese patient View